Skip Navigation


NDT Advance Access originally published online on July 29, 2007
Nephrology Dialysis Transplantation 2007 22(12):3495-3500; doi:10.1093/ndt/gfm491
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/12/3495    most recent
gfm491v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cramer, C. H.
Right arrow Articles by Brophy, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cramer, C. H., II
Right arrow Articles by Brophy, P. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org



Clinical presentation and outcome in a cohort of paediatric patients with membranous lupus nephritis*

Carl H. Cramer, II1, Michelle Mills2, Rudolph P. Valentini3, William E. Smoyer2, Hillary Haftel4 and Patrick D. Brophy2

1Pediatric Nephrology, Pediatric and Adolescent Medicine Department, Mayo Clinic, Rochester, MN 55905, 2Pediatric Nephrology, C.S. Mott Children's Hospital, Ann Arbor, MI 48109, 3Pediatric Nephrology, Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI 48201 and 4Pediatric Rheumatology Department of Pediatrics, C.S. Mott Children's Hospital, Ann Arbor, MI 48109, USA

Correspondence to: C. H. Cramer II, Pediatric Nephrology, 200 First Street SW, Rochester, MN 55095, USA. Email: cramer.carl{at}mayo.edu



  Abstract

Background. Membranous glomerulopathy accounts for 28% of the biopsy-proven systemic lupus erythematosus nephritis in paediatric patients at the time of first biopsy, yet minimal data are available regarding outcomes in this population.

Methods. We present a retrospective analysis of 26 paediatric patients with World Health Organization class V lupus nephritis. Patients were subdivided based on renal biopsy findings into the following subclasses: 16 (63%) Va, 2 (9%) Vb, 7 (26%) Vc and 1 (4%) Vd. We evaluated outcomes of renal function and urine protein to creatinine ratio (UPr/UCr).

Results. Mean follow-up time was 38.6 (±22) months. Eight patients at presentation had a glomerular filtration rate (GFR) <90 ml/min/1.73 m2, six with Va and two with Vc. The initial presenting serum creatinine was predictive of renal function at last follow-up in class Va and Vb patients (P = 0.002). Twenty-one of the 26 patients had GFR ≥ 90 ml/min/1.73 m2 at last follow-up; the five patients with GFR <90 ml/min/1.73 m2 were all lupus class Va. Cyclophosphamide (CTX) therapy did not demonstrate a significant improvement in outcome. The following parameters failed to predict GFR at last follow-up visit: blood pressure, C3, C4 and UPr/UCr.

Conclusions. The initial creatinine in patients with classes Va and Vb lupus nephritis predicted follow-up renal function. We found no correlation with outcome based on therapy with CTX and/or mycophenolate mofetil.

Keywords: membranous nephropathy; paediatrics; systemic lupus erythematosus


*This manuscript was presented in abstract form at the 2005 Pediatric Academic Societies’ Meeting in Washington D.C.

Received for publication: 21. 3.07
Accepted in revised form: 28. 6.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.